Mutants having capability to produce 1, 4-butanediol and method for preparing 1, 4-butanediol using the same

US9920325B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9920325-B2
Application numberUS-201514802681-A
CountryUS
Kind codeB2
Filing dateJul 17, 2015
Priority dateSep 7, 2007
Publication dateMar 20, 2018
Grant dateMar 20, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A mutant capable of producing 1,4-butanediol and a method of preparing 1,4-butanediol using the same are provided. The mutant microorganism is prepared by introducing and amplifying genes encoding enzymes converting succinate into 4-hydroxybutyrate and 4-hydroxybutyrate into 1,4-butanediol in a microorganism capable of producing succinate. The method includes culturing the mutant in a medium containing carbohydrate and obtaining 1,4-butanediol from the culture. Thus, 1,4-butanediol, which is essential in chemical industry, can be prepared in a biological process.

First claim

Opening claim text (preview).

The invention claimed is: 1. An isolated mutant microorganism exhibiting high production of 1,4-butanediol, which is prepared by introducing or amplifying genes encoding enzymes converting succinate into 4-hydroxybutyrate, and 4-hydroxybutyrate into 1,4-butanediol, in a Lumen bacteria capable of producing succinate, wherein the Lumen bacteria have inactive genes encoding lactate dehydrogenase (ldhA) and pyruvate-formate lyase (pfl), and produce succinate in high concentration without substantial production of other organic acids in an anaerobic condition, and wherein the gene encoding the enzyme converting succinate into 4-hydroxybutyrate is selected from the group consisting of genes encoding succinyl-CoA transferase (Cat1), succinate semialdehyde dehydrogenase (SucD), 4-hydroxybutyrate dehydrogenase (4hbD) and 4-hydroxybutyrate dehydrogenase (GHB). 2. The isolated mutant microorganism according to claim 1 , wherein the Lumen bacteria have inactive genes encoding lactate dehydrogenase (ldhA), pyruvate-formate lyase (pfl), phosphotransacetylase (pta) and acetate kinase (ackA), and produce succinate in high concentration without substantial production of other organic acids in an anaerobic condition. 3. The isolated mutant microorganism according to claim 1 , wherein the Lumen bacteria have inactive genes encoding lactate dehydrogenase (ldhA), pyruvate-formate lyase (pfl) and phosphopyruvate carboxylase (ppc), and produce succinate in high concentration without substantial production of other organic acids in an anaerobic condition. 4. The isolated mutant microorganism according to claim 1 , wherein the Lumen bacteria are selected from the group consisting of Mannheimia species, Actinobacillus species and Anaerobiospirillum species. 5. The isolated mutant microorganism according to claim 4 , wherein the Lumen bacteria are Mannheimia species. 6. The isolated mutant microorganism according to claim 5 , wherein the Lumen bacteria are selected from the group consisting of Mannheimia succiniciproducens MBEL55E (KCTC 0769BP), and Mannheimia species LPK (KCTC 10558BP), LPK4 and LPK7 (KCTC 10626BP). 7. The isolated mutant microorganism according to claim 1 , wherein the gene encoding the enzyme converting succinate into 4-hydroxybutyrate is isolated from Clostridium kluyveri. 8. The isolated mutant microorganism according to claim 1 , wherein the gene encoding Cat1 has a nucleotide sequence of SEQ ID NO: 1, the gene encoding SucD has a nucleotide sequence of SEQ ID NO: 2, the gene encoding 4hbD has a nucleotide sequence of SEQ ID NO: 3, and the gene encoding GHB has a nucleotide sequence of SEQ ID NO: 4. 9. The isolated mutant microorganism according to claim 1 , wherein the mutant comprises a gene encoding Cat1; a gene encoding SucD; and a gene encoding 4hbD or a gene encoding GHB. 10. The isolated mutant microorganism according to claim 1 , wherein the gene encoding the enzyme converting 4-hydroxybutyrate into 1,4-butanediol is isolated from Clostridium acetobutylicum. 11. The isolated mutant microorganism according to claim 1 , wherein the gene encoding the enzyme converting 4-hydrxoybutyrate into 1,4-butanediol is a gene encoding 4-hydroxybutyrate-CoA transferase and a gene encoding alcohol dehydrogenase reducing 4-hydroxybutyrate-CoA; or a gene encoding phosphotransbutyrylase, a gene encoding butyryl kinase and a gene encoding alcohol dehydrogenase reducing 4-hydroxybutyrate-CoA. 12. The isolated mutant microorganism according to claim 11 , wherein the gene encoding 4-hydroxybutyrate-CoA transferase has a nucleotide sequence of SEQ ID NO: 5. 13. The isolated mutant microorganism according to claim 11 , wherein the gene encoding phosphotransbutyrylase and the gene encoding butyryl kinase have nucleotide sequences of by SEQ ID NOs: 6 and 7, respectively. 14. The isolated mutant microorganism according to claim 11 , wherein the alcohol dehydrogenase is butyl-CoA dehydrogenase isolated from Clostridium acetobutylicum. 15. The isolated mutant microorganism according to claim 14 , wherein the gene encoding butyl-CoA dehydrogenase has a nucleotide sequence of SEQ ID NO: 8 or 9. 16. The isolated mutant microorganism according to claim 1 , wherein the mutant has an inactive gene associated with conversion of succinate semialdehyde into succinate. 17. The isolated mutant microorganism according to claim 16 , wherein the gene associated with conversion of succinate semialdehyde into succinate is a gene encoding succinic semialdehyde dehydrogenase (GabD). 18. The isolated mutant microorganism according to claim 17 , wherein the gene encoding GabD has a nucleotide sequence of SEQ ID NO: 10. 19. The isolated mutant microorganism according to claim 1 , wherein a gene encoding C4-dicarboxylate transport protein (DctA) associated with transport of succinate is further introduced or amplified in the mutant. 20. The isolated mutant microorganism according to claim 19 , wherein the gene encoding DctA has a nucleotide sequence of SEQ ID NO: 11. 21. An isolated mutant microorganism exhibiting high production of 1,4-butanediol, which is prepared by introducing or amplifying: a gene encoding succinyl-CoA transferase (Cat1); a gene encoding succinate semialdehyde dehydrogenase (SucD); a gene encoding 4-hydroxybutyrate dehydrogenase (4hbD) or 4-hydroxybutyrate dehydrogenase (GHB); a gene encoding 4-hydroxybutyrate-CoA transferase, or a gene encoding phosphotransbutyrylase (Ptb) and a gene encoding butyryl kinase (Buk); and a gene encoding butyl-CoA dehydrogenase, in a Lumen bacteria capable of producing succinate, wherein the Lumen bacteria have inactive genes encoding lactate dehydrogenase (ldhA) and pyruvate-formate lyase (pfl), and produce succinate in high concentration without substantial production of other organic acids in an anaerobic condition. 22. The isolated mutant microorganism according to claim 21 , wherein a gene encoding GabD is inactivated in the mutant. 23. The isolated mutant microorganism according to claim 21 , wherein a gene encoding DctA associated with transport of succinate is introduced or amplified in the mutant. 24. A method of preparing 1,4-butanediol, comprising: culturing the mutant microorganism according to claim 1 in a medium containing a carbon source; and obtaining 1,4-butanediol from the medium.

Assignees

Inventors

Classifications

  • acting on CH-OH groups as donors (1.1) · CPC title

  • acting on the CH-CH group of donors (1.3) · CPC title

  • C12N15/77Primary

    for Corynebacterium; for Brevibacterium · CPC title

  • Butyryl-CoA dehydrogenase (1.3.99.2), i.e. short chain acyl-CoA dehydrogenase · CPC title

  • Succinate-semialdehyde dehydrogenase (NAD+) (1.2.1.24) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9920325B2 cover?
A mutant capable of producing 1,4-butanediol and a method of preparing 1,4-butanediol using the same are provided. The mutant microorganism is prepared by introducing and amplifying genes encoding enzymes converting succinate into 4-hydroxybutyrate and 4-hydroxybutyrate into 1,4-butanediol in a microorganism capable of producing succinate. The method includes culturing the mutant in a medium co…
Who is the assignee on this patent?
Lg Chemical Ltd, Korea Advanced Inst Sci & Tech
What technology area does this patent fall under?
Primary CPC classification C12N15/77. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).